Keyword

DAS28

Description: DAS28 is a composite disease activity score for rheumatoid arthritis, calculated from assessments of 28 joints and other clinical measures.

Primary topic: Rheumatoid Arthritis Research and Therapies (78%)

OpenAlex ID: keywords/das28

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

2003 · J. S. Smolen, F. C. Breedveld, et al. · Lara D. Veeken · 1,072

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

2005 · Daniel Aletaha, Valerie PK Nell, et al. · Arthritis Research & Therapy · 1,069

PDF

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

2017 · Peter C. Taylor, Edward C. Keystone, et al. · New England Journal of Medicine · 950

PDF

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

2008 · G Wells, J-C Becker, et al. · Annals of the Rheumatic Diseases · 880

PDF

The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.

2006 · D Aletaha, J Smolen · PubMed · 848

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

2008 · Paul Emery, Ferdinand C Breedveld, et al. · The Lancet · 821

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis

2004 · V. P. K. Nell · British journal of rheumatology · 820

PDF

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

2004 · David W McCarey, Iain B McInnes, et al. · The Lancet · 818

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

2009 · G Jones, A Sebba, et al. · Annals of the Rheumatic Diseases · 797

PDF

Development and validation of a composite disease activity score for juvenile idiopathic arthritis

2009 · Alessandro Consolaro, Nicolino Ruperto, et al. · Arthritis Care & Research · 790

PDF

Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

2006 · R. N. Maini, P. C. Taylor, et al. · Arthritis & Rheumatism · 790

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

2013 · Cem Gabay, Paul Emery, et al. · The Lancet · 671

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

2005 · Christian E. Antoni, Arthur Kavanaugh, et al. · Arthritis & Rheumatism · 640

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

2007 · Geertje M Bartelds, Carla A Wijbrandts, et al. · Annals of the Rheumatic Diseases · 562

Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states

2005 · Daniel Aletaha, Michael M. Ward, et al. · Arthritis & Rheumatism · 542

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

2007 · M Schiff, M Keiserman, et al. · Annals of the Rheumatic Diseases · 540

Disease activity of rheumatoid arthritis during pregnancy: Results from a nationwide prospective study

2008 · Yaël A. de Man, Radboud J. E. M. Dolhain, et al. · Arthritis Care & Research · 532

A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis

2012 · Binu Chandran, Ajay Goel · Phytotherapy Research · 524

PDF

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

2004 · J. Fransen · British journal of rheumatology · 484

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study

2009 · Tuulikki Sokka, Sergio Toloza, et al. · Arthritis Research & Therapy · 476

PDF

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

2005 · J. S. Smolen, C. Han, et al. · Arthritis & Rheumatism · 462

Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis

2004 · J J Haringman, D M Gerlag, et al. · Annals of the Rheumatic Diseases · 457

PDF

LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept study

2010 · M. C. Genovese, F. Van den Bosch, et al. · Arthritis & Rheumatism · 451

Evaluation of a novel 7‐joint ultrasound score in daily rheumatologic practice: A pilot project

2009 · M. Backhaus, S. Ohrndorf, et al. · Arthritis Care & Research · 431

Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values

2006 · Eisuke Inoue, Hisashi Yamanaka, et al. · Annals of the Rheumatic Diseases · 419

PDF

Works count: 9,990

Citation count: 124,800